INTELLIGENCE IN ACTION

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

August 01, 2018

The need for greater price transparency in healthcare is all over the news. Policy makers across the country have taken up the cause. Patients are demanding real change, as healthcare costs continue to rise and hit pocketbooks hard. Given that Surescripts processes nearly 5 million electronic prescriptions each day, we’re focused on leveraging technology to improve prescription price transparency specifically. Americans spent $425 billion on prescriptions in 2015, a more than 12 percent increase from 2014. And the nation’s spending on medicines is forecasted to reach $610-640 billion in 2020.

In a recent Becker’s Healthcare podcast, Surescripts Chief Executive Officer Tom Skelton talked about how the Surescripts Network Alliance is taking prescription price transparency from hot topic to healthcare reality. He also talked about why.

“We’re trying to step back and look at things more holistically to ensure we’re addressing issues that may be impacting medication adherence,” Skelton said. “We know that ten percent of people who abandon their prescriptions do so because of cost. We also have data that shows that about 40 percent of patients will abandon treatment when a prior authorization is required.”

Tom Skelton | Becker's Hospital Review

For more perspective on the criticality of price transparency, interoperability and more, check out the article and podcast

Related Articles

March 04, 2020

Prescription Price Transparency: Good for Patients, Good for Health Plans

Receiving a diagnosis at a routine doctor’s appointment can be incredibly scary, even for something as treatable as type 2 diabetes. But the right price transparency tools—or lack thereof—can make (or break) that experience for a patient.  Read more...
February 25, 2020

Price Transparency: It’s in the Best Interest of Patients and Providers

“In all my years in health IT this is one of the most exciting and most rapidly adopted clinical decision support tools I’ve ever been associated with,” said Andrew Mellin, MD and vice president of Medical Informatics at Surescripts, referring to Surescripts’ prescription price transparency tool Read more...
February 18, 2020

Patients Are Ready to Talk Dollars with Their Doctors

With more skin in the game than ever before, patients are becoming savvy, engaged and discerning consumers. They know that the name-brand drug with the $300 monthly price tag may not be the only option. They want a healthcare provider who has the information needed to compare and guide them to alternatives that achieve the same or similar outcome. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX